Journal of hepatologyJClub
Emerging strategies for hepatocellular carcinoma surveillance: Abbreviated MRI, biomarkers and benefit stratification.
Journal of hepatology · · Review
Ioannou, Jepsen + 1 more
Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
Abbreviated MRI protocols and blood-based biomarkers show promise for improving hepatocellular carcinoma surveillance accuracy and patient adherence.
- Why it matters: Current ultrasound and AFP screening have limited sensitivity for early-stage HCC and poor adherence, creating a critical need for more effective, patient-friendly methods that can improve clinical outcomes.
- What they did: The study reviews emerging HCC surveillance strategies, including dynamic contrast-enhanced and non-contrast abbreviated MRI, as well as blood-based biomarker panels, emphasizing the importance of benefit-based patient selection.
- The result: Implementing validated, benefit-stratified surveillance approaches could enhance early detection and treatment, ultimately leading to better clinical outcomes, even among patients at varying levels of HCC risk.
The findingWhy it mattersWhat they didThe result